Prognostic factors for primary gastrointestinal lymphoma

Area of Science:

• Oncology
• Gastroenterology
• Pathology

Background:

• Primary gastrointestinal lymphoma is a common extranodal non-Hodgkin's lymphoma.
• There is a lack of consensus on its classification, staging, and management.
• This study reviews management of Chinese patients in Hong Kong.

Purpose of the Study:

• To report the management experience of 425 Chinese patients with primary gastrointestinal lymphoma.
• To identify prognostic factors for better survival.
• To evaluate treatment modalities.

Main Methods:

• Retrospective analysis of 425 patients from 1975 to 1993.
• Classification using the Working Formulation and Manchester staging system.
• Immunophenotyping performed on 47% of patients.
• Treatment included surgery and chemotherapy.

Main Results:

• Stomach (56%) and small intestine (31%) were the most common sites.
• Diffuse large cell lymphoma was the most frequent type (43%).
• 63% achieved complete remission with a 42% relapse rate; 47% were disease-free at 5 years.
• Younger age (<60), low-grade histology, early stage (I/II), and absence of bulky disease were significant prognostic factors.
• Chemotherapy played an important role; aggressive surgery did not improve outcomes for gastric lymphoma.

Conclusions:

• Chemotherapy is vital in managing gastrointestinal lymphoma.
• Individualized treatment based on refined classification and prognostic variables is recommended.
• Prospective randomized studies are needed to define optimal treatment strategies involving surgery, chemotherapy, and radiotherapy.